Clinical trial · Interventional
Multimodal Prehabilitation Program for Women Undergoing Gynecologic Oncology Surgery
Role of Multimodal Prehabilitation Program in Improving Surgical Outcomes for Women Undergoing Gynecologic Oncology Surgery
NCT07188662CI-TRIAL-00095663completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to evaluate the role of multimodal Prehabilitation program on improve surgical outcomes after gynecological oncology surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynecologic Oncology Patient | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| group (B) Prehabilitation care combine with ERAS post-operative care | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Conventional group
- description
- Conventional group (woman received hospital care at previous year as a retrospective sample to prevent risk of bias) equal 70 woman
- type
- EXPERIMENTAL
- label
- Prehabilitation group
- description
- Prehabilitation group (woman who will receive prehabilitation care combine with ERAS post-operative care as a prospective sample) equal 70 woman
- interventionNames
- Procedure: group (B) Prehabilitation care combine with ERAS post-operative care
Primary outcomes (3)
- measure
- changing the postoperative morbidity
- timeFrame
- "up to 30 days postoperative"
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Newly diagnosed woman with gynecologic cancer by imaging \&histopathology * Accept participation in the study. Exclusion Criteria: * Patient with advanced and metastatic stage * Patient who received neoadjuvant chemotherapy * Patient who have psychological disorder such as suicidal attempt * Patient who have cerebral stroke, hemiplegia or paralyses
References
Publications (0)
Data not yet available
No reference posted for this study.